HIV‑infected patients have a higher risk of developing cutaneous reactions than the general population, which has a significant impact on patients’ current and future care options. The severity of cutaneous adverse reactions varies greatly, and some may be difficult to manage. HIV‑infected patients just at the beginning of antiretroviral therapy can frequently show a wide variety of adverse drug effects such as erythema multiforme, maculopapular rash urticarial reaction, drug rashes, Stevens–Johnson syndrome and toxic epidermal necrolysis.
Loading....